|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.7 TWD | -0.64% |
|
+1.84% | -13.62% |
Medigen Biotechnology Corp. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 164.25 million compared to TWD 484.71 million a year ago.
Net loss was TWD 94.69 million compared to TWD 81.71 million a year ago. Basic loss per share from continuing operations was TWD 0.68 compared to TWD 0.59 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.62% | 165M | |
| +0.17% | 42.19B | |
| +10.92% | 42.24B | |
| +44.30% | 40.15B | |
| -6.20% | 28.31B | |
| +5.23% | 24.63B | |
| -24.79% | 18.2B | |
| +26.69% | 12.01B | |
| -3.13% | 11.76B | |
| +6.57% | 10.4B |
MEDIGEN BIOTECHNOLOGY CORP. 
